Syndecan-1 in the Serum of Deceased Kidney Donors as a Potential Biomarker of Kidney Function
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2024.12.031 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Pavel Navratil und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; Charles University, Faculty of Medicine in Hradec Kralove,…. Hauptthemen laut MEDLINE: Syndecan-1, Kidney Transplantation, Tissue Donors, Kidney Failure, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Univerzita Karlova v Praze, Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
BACKGROUND: The process of kidney transplantation remains the optimal treatment for end-stage renal disease, offering improved quality of life and increased survival rates compared to long-term dialysis. However, despite advances in surgical techniques, immunosuppression regimens, and post-operative care, there are still significant challenges in predicting the organ's status and long-term outcomes of transplantation. Among the many factors that influence graft survival, the quality of the donated organ plays a fundamental role. There is an ongoing need for accurate and reliable biomarkers. Syndecan-1 is found in the endothelial glycocalyx and shed at a higher rate into the blood during systemic pathological conditions. The aim of this study is to evaluate the potential of serum syndecan-1 levels as a biomarker for assessing donor kidney quality and to investigate its correlation with donor characteristics and short-term outcomes in kidney recipients. MATERIAL AND METHODS: We investigated serum syndecan-1 levels in 80 deceased donors and correlated them with donor characteristics and short-term outcomes (defined as delayed graft function - defined as the need for dialysis within the first week post-transplantation and renal function at 3 months post-transplantation - assessed using serum creatinine levels) in 104 corresponding kidney recipients. This single-center retrospective observational cohort study was conducted from April to December 2021. RESULTS: The donor pool consisted of 65% males with a median age of 53 years. Of these, 45 donors (56%) were classified as extended criteria donors. Higher syndecan-1 levels correlated with the last creatinine levels before organ procurement (R = 0.32, p = 0.01) and were marginally higher in donors with acute kidney injury (p = 0.07). However, syndecan-1 levels were not associated with short-term outcomes in kidney recipients (renal function at 3 months). CONCLUSIONS: The data suggests syndecan-1 could be a potential biomarker for assessing donor kidney quality, although its implications on recipient outcomes require further study. This pilot investigation underscores the importance of syndecan-1 in evaluating organ quality but highlights the necessity for more extensive research to validate these findings and explore their implications in transplant success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic. Electronic address: pavel.navratil2@f…
- Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
- Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic; Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Depart…
Förderung
- Univerzita Karlova v Praze
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Navratil, P., Sahi, S., Hruba, P., Ticha, A., Timkova, K., Viklicky, O., Cerny, V., & Astapenko, D. (2025). Syndecan-1 in the Serum of Deceased Kidney Donors as a Potential Biomarker of Kidney Function. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.12.031
Vancouver
Navratil P, Sahi S, Hruba P, Ticha A, Timkova K, Viklicky O, et al. Syndecan-1 in the Serum of Deceased Kidney Donors as a Potential Biomarker of Kidney Function. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2024.12.031
BibTeX
@article{Navratil2025,
author = {Navratil, Pavel and Sahi, Sukhdeep and Hruba, Petra and Ticha, Alena and Timkova, Katarina and Viklicky, Ondrej and Cerny, Vladimir and Astapenko, David},
title = {Syndecan-1 in the Serum of Deceased Kidney Donors as a Potential Biomarker of Kidney Function},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2024.12.031}
}
EUVIMED